Myopia Control with MiSight and Atropine
Understanding Myopia and Why It Matters
Myopia, or nearsightedness, occurs when the eyeball grows too long. Light focuses in front of the retina instead of on it. This makes far objects look blurry while close objects stay clear. Myopia often starts between ages 6 and 14. It tends to get worse as a child grows and may level off in early adulthood.
Standard glasses fix blurry vision but do not address the cause. They do not slow the eye growth that drives myopia. Without specific myopia control, the eye keeps getting longer. Over time, this raises the risk of serious eye problems.
Several things affect a child risk of developing myopia or reaching high levels.
- Genetics: children with myopic parents have a higher risk of myopia
- Screen time: more near work and screen use are linked to faster growth
- Outdoor time: less time outside is linked to faster myopia growth
- Age of onset: starting younger often leads to higher myopia by adulthood
- Early action can slow how fast myopia gets worse
Risks of Uncontrolled Myopia Progression
Myopia control is about more than clear vision. High myopia that is not managed raises the risk of serious eye problems. These include retinal detachment, glaucoma, cataracts, and vision loss from myopic macular disease. Slowing myopia reduces these long-term risks.
Myopia control uses treatments that slow eye growth. Starting early, during peak growth years, gives the best results. The AAO Preferred Practice Pattern on Refractive Errors (2022) lists both low-dose atropine and soft multifocal contact lenses as proven options for children.
Ask about myopia control if your child prescription gets stronger each year. Children with two myopic parents are at higher risk. Your eye doctor will review your child prescription history and measure axial length to guide the plan.
Atropine Eye Drops for Myopia Control
Low-dose atropine eye drops help slow myopia growth. They are used in doses from 0.01 to 0.05 percent and applied once daily, often at bedtime. According to EyeWiki (2023), low-dose atropine is off-label in many regions. It is often compounded because commercial low-concentration versions are limited.
Atropine blocks certain receptors in the eye that control scleral growth. This reduces the signals that cause the eye to grow longer. Clinical evidence confirms that atropine slows myopia growth in children.
The LAMP Study (Yam et al., Ophthalmology 2019) found that 0.05 percent atropine reduced myopia growth by about 67 percent compared to placebo at one year. Lower concentrations of 0.025 and 0.01 percent showed smaller but still meaningful effects. Side effects such as light sensitivity and near blur are dose-dependent and are less common at lower concentrations (EyeWiki, 2023).
Some children see myopia speed up briefly after stopping atropine. This is more likely if treatment is stopped all at once. Tapering the dose slowly under a doctor care helps reduce this risk. Regular visits help the doctor decide when and how to taper safely.
MiSight Contact Lenses for Myopia Control
MiSight 1 day lenses received FDA approval in 2019 as the first contact lens cleared to slow myopia growth in children (FDA, 2019). They are daily disposable soft lenses with a dual-focus design. A clear central zone corrects vision. Concentric outer zones signal the eye to slow its growth.
MiSight lenses are indicated for children initially fit between ages 8 and 12 (FDA, 2019). They are suited for children with mild to moderate myopia. Prescriptions from about -0.75 to -4.00 diopters are the typical range for candidacy, though your eye doctor will determine fit based on your child specific prescription and corneal measurements.
Fresh lenses each day are one of the biggest benefits of MiSight. No cleaning solutions or cases are needed. New lenses each day also reduce the risk of deposits and eye infections. This supports better comfort and steady wear.
- No cleaning solutions or lens cases needed
- Lower infection risk from daily replacement
- Fresh lens comfort each day supports consistent wear
Combined Treatment Strategies
Atropine and MiSight work in different ways. Atropine slows scleral growth at the cellular level. MiSight changes how peripheral light reaches the retina to reduce signals for eye growth. According to EyeWiki (2023), combining both is used for children with faster growth or a strong family history of high myopia.
Your eye care provider will look at many things when building a plan. Age, prescription, rate of change, family history, and lifestyle all matter. The plan is reviewed and adjusted at each visit as your child grows.
Myopia control needs regular check-ins. Axial length and refraction tests track eye growth. If the eye keeps growing faster than expected, the plan may change. Good habits like outdoor time and breaks from near work support the treatment.
Who Is a Good Candidate for Treatment
Children aged 6 to 15 years with fast-growing myopia benefit most from atropine. It is most useful for prescriptions between about -2.00 and -6.00 diopters. Low doses can be used long-term with proper check-ups. It also works for children not yet ready for contact lenses.
MiSight is indicated for children initially fit between ages 8 and 12 with mild to moderate myopia. The child must be ready to handle contact lenses each day. Parental support for insertion, removal, and disposal is key to success.
A good plan depends on more than just age and prescription.
- Overall eye health and corneal shape
- Tear film and dry eye status
- Ability to keep up with daily use and follow-up visits
- Parent help with daily use and check-ups
- Child readiness and comfort with the treatment
What to Expect at Myopia Control Appointments
The first visit includes refraction testing, axial length measurement, and an eye health check. These establish a baseline for tracking future changes. Tools such as optical length testing and corneal shape mapping may be used. Results guide treatment choice and monitoring.
Follow-up visits typically happen every six months. These track myopia growth and eye growth. Your provider may adjust atropine dosage or review lens wear. Any changes in comfort, vision, or fit are addressed. These visits are needed even when your child feels well.
Success is measured by tracking changes in prescription and axial length over time. Slower increases in both show that myopia is being controlled. Your provider will compare these to typical rates without treatment and explain what the results mean for long-term eye health.
Questions About MiSight and Atropine Treatment
Treatment usually continues throughout the peak myopia growth years. This is often a span of three to five years or until the prescription levels off in early adulthood. The exact duration depends on how fast myopia is progressing and how well the child is responding to treatment.
Low-dose atropine may cause mild light sensitivity or brief near blur, but these side effects are dose-dependent and much less frequent at lower concentrations (EyeWiki, 2023). Most children on low-dose atropine do not notice strong side effects. MiSight daily disposable lenses have a low complication rate when used correctly.
Yes. Combining these treatments is used for children with faster growth or a strong family history of high myopia (EyeWiki, 2023). Your eye doctor will assess your child needs and plan the appropriate approach. Both treatments together address different pathways that drive myopia.
Low-dose atropine does not cause permanent changes to the eye structure. Side effects at low doses are minimal and reversible. If treatment is stopped, the eye reverts to its prior state without lasting effects from the medication itself. Your eye doctor will monitor for any changes at each visit.
Spending one to two hours outdoors each day is associated with slower myopia growth. Taking frequent breaks during near work and using proper lighting during screen time also helps. These habits support the treatment your child is already using but do not replace it.
Yes. Myopia can continue to progress into the late teen years. Starting control later still provides benefit by slowing further progression. The degree of benefit depends on how much progression remains. Your eye doctor will assess whether treatment is appropriate based on current prescription and axial length trends.
Start Protecting Your Child Vision Today
Ask our office about myopia control options for your child. Early action helps reduce the risk of serious eye problems later in life. We will assess your child prescription history, axial length, and overall eye health to find the right plan. Schedule a visit to get started.